5 EASY FACTS ABOUT ABBV-744 COMBINATION THERAPY WITH CHEMOTHERAPY DESCRIBED

In Segment A, participants will get unique doses and schedules of oral ABBV-744 tablet to determine Secure dosing program. More individuals will likely be enrolled with the discovered monotherapy dosign routine. In Phase B, members will receive oral ruxolitinib and ABBV-744 will be specified as "insert-on" therapy. In Segment C, contributors will a